BioSpace News Archive

Biotech Bay

Link Between Diabetes and Arterial Restriction Could Lead to New Treatments

Researchers at UC Davis Health identified a new molecular link that could potentially lead to new diabetes treatments and potential cardiovascular therapies. They published their research in The Journal of Clinical Investigation.

July 22, 2019
·
2 min read
·
Mark Terry
DNA Microscopy Changes the Way Scientists Analyze DNA

A new technique, DNA microscopy, is allowing scientists to visualize DNA in a way not previously possible. And there isn’t even an actual microscope involved.

July 22, 2019
·
3 min read
·
Gaius J. Augustus, PhD
Business

ADL Bionatur Solutions and Amyris Inc. Expand Contract to 2020

ADL Bionatur Solutions (MAB: ADL), a company specialized in research and development of sustainable health and beauty products, services and industrial fermentation production, announces the expansion of its existing production agreement with Amyris, Inc.

July 22, 2019
·
5 min read
Drug Development

Arcutis, Inc Announces Positive Top Line Results for Phase 2b Clinical Trial Evaluating ARQ-151 as a Potential Topical Treatment for Plaque Psoriasis

Arcutis, Inc., a privately held immuno-dermatology drug development company addressing significant unmet needs in dermatology, announced positive top line results for its Phase 2b study evaluating ARQ-151 as a potential topical treatment for plaque psoriasis.

July 22, 2019
·
5 min read
Combined online self-management for pain, associated anxiety and depression works

Online self-management helps; for some the online system plus nurse telecare helps more

July 22, 2019
·
4 min read
FDA

FDA Approves First Treatment for Oral Ulcers Associated with Rare Inflammatory Disease

The FDA approval marks the first for oral ulcers associated with Behçet’s Disease and the third for Otezla.

July 22, 2019
·
3 min read
·
Alex Keown
Business

DURECT and Gilead Collaborate on HIV Therapy in Potential $320 Million+ Deal

“We are pleased to be working on this program with Gilead given their expertise and global leadership in the HIV and HBV fields,” stated James E. Brown, president and chief executive officer of DURECT.

July 22, 2019
·
3 min read
·
Mark Terry
FDA

Baxter International Nabs FDA Approval for Insulin IV Infusion

Myxredlin is intended for use only in acute care settings under medical supervision.

July 22, 2019
·
2 min read
·
Alex Keown
18th Hospital Management Asia to be held in Hanoi on 11-12 September

Hospital Management Asia 2019, the annual event for Asian healthcare leaders, will be held September 11-12, 2019, at the National Convention Centre of Vietnam.

July 22, 2019
·
4 min read
Congenica simplifies software branding and enhances platform with CNV calling to deliver genomic medicine globally

Congenica, a digital health company enabling accelerated genomic data interpretation, today announced it has renamed its software platformCongenica® and expanded its capabilities to include CNV calling for exome and gene panel sequencing.

July 22, 2019
·
6 min read